Myasthenia Gravis on 42 Year Old Woman: A Case Report


  • Tania Tamara Medical Faculty, Lampung University
  • Fitriyani



Myasthenia Gravis, Harvey Maslan ( ).


Myasthenia gravis (MG) is an autoimmune disease, MG attacks the postsynaptic membrane, disrupts neuromuscular transmission, and causes skeletal muscle weakness and fatigue. Myasthenia gravis is a treatable disease but can result in significant morbidity and even death. This article aims to discuss the diagnosis, therapy, and prevention of disease progression. A 42-year-old woman presented with complaints of weakness all over the body since 4 years ago, which has worsened in the last 2 months, accompanied by shortness of breath, coughing, difficulty speaking, and a nasal voice. Physical examination revealed ptosis (+/+), motor strength 3/3/3 / 3/3/3. Laboratory examination showed leukocytes 11,500/µL. Electromyography (EMG) and nerve conduction velocity (NCV) examination showed a 10% reduction in repetitive nerve stimulation (RNS), Harvey Maslan (+). The clinical symptoms of MG are fluctuating weakness in the extra-ocular, bulbar, and proximal muscles. Signs of muscle weakness include unilateral or bilateral ptosis, binocular diplopia, inability to lift the head straight, dysphagia, and dysarthria. MG can progress generally to proximal muscle weakness with varying degrees of severity. The main treatments for MG are cholinesterase enzyme inhibitors and immunosuppressive agents. Previously, a case of myasthenia gravis was described in a 42-year-old female patient. The diagnosis of this case was made based on a previous history of myasthenia gravis, symptoms of weakness in the ocular, bulbar, and extremity muscles. A possible risk factor for re-triggering MG symptoms in patients is infection. Establishing the current diagnosis and treatment options for MG play an important role in preventing worse disease progression.


Kusuma NS. Miastenia Gravis. In: Rianawati SB, Munir B, editors. Buku Ajar Neurologi. Jakarta: Sagung Seto; 2017:95–109.

Salsabila K, Mutiara H. Miastenia Gravis: Etiologi, Patofisiologi, Manifestasi Klinis, Penegakkan Diagnosis dan Tatalaksana. Jurnal Medula. 2023. Vol 13(1):115-122

Sosinsky MS dan Kaufmann P. 2010. Myasthenia Gravis & Other Disorders of the Neuromuscular Junction. in: Brust JCM (ed.). Neurology: Current Diagnosis and Treatment. USA: Lange Medical Books/McGraw-Hill. Hal. 350-356

Drachman DB dan Amato AA. 2012. Myastenia Gravis and other Disease of the Neuromuscular Junction. In : Hauser SL.ed. Harrison’s Neurology in Clinical Medicine. San Fransisco: McGraw- Hill. Hal. 527-535

Shah AK, Goldenberg WD. Myasthenia gravis [internet]. New York: MedScape; 2016 [Diakses tanggal 8 Agustus 2016]. Tersedia dari:

Gilhus NE. Myasthenia Gravis. N Engl J Med. 2016;3756:2570–81.

Hakim M, Safri AY, Wiratman W. Miastenia gravis. In Buku ajar Neurologi. Jakarta: Departemen Neurologi FKUI- RSCM; 2017.

Trouth AJ, Dabi A, Solieman N. Myasthenia Gravis: A Review. Autoimmune Disease, 2012.

Suresh AB, Asuncion RM. Myasthenia gravis [internet]. Philadelphia: StatPearls. 2022. Tersedia dari: 559331/

Howard JF. In: Myasthenia gravis a manual for health care provider. 1st Edition. USA: Myasthenia Gravis Foundation of America. 2008; pp:8-14.

Skowronski G, Saxena MK. Neuromuscular Disease in Intensive Care. In: Bersten AD, Soni N. Oh’s Intensive Care Manual 7th ed. Butterworth Heinemann Elsevier. 2014.

Melzer N, Ruck T, Fuhr P, Gold R, Hohlfeld R, Marx A, et al. Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society. J Neurol. 2016;263(8):1473-94.



How to Cite

Tania Tamara, & Fitriyani. (2024). Myasthenia Gravis on 42 Year Old Woman: A Case Report. Medical Profession Journal of Lampung, 14(6), 1056-1060.




Most read articles by the same author(s)

1 2 > >>